: Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio
Amgen Inc. is acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.
Amgen Inc. is acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.
The so-called Index Effect — a stock’s rise or fall when it’s added or deleted from an index — no longer exists.
Consumers will be more likely to seek out cheaper alternatives for jeans than for handbags in what is likely to be a ‘choppy’ year, Goldman...
FTX founder Sam Bankman-Fried will testify to a House panel on Tuesday remotely instead of in person.
A struggling U.S. stock market will next year have to contend with relatively attractive European equities after a recent shift toward value stocks, according to...
The U.S. budget deficit widened to $248.5 billion in November, up from $191.3 billion in the same month last year, the Treasury Department said Monday.
The high rate of U.S. inflation probably slowed again in November, but not enough to ease worries at the Federal Reserve or prevent the central...
U.S. retail gasoline prices have declined for five weeks in a row, with average prices on track to fall below $3 by Christmas, says GasBuddy.
U.S. known cases of COVID continued to rise steadily on Monday, along with hospitalizations, fatalities and test-positivity rates.